Trial intelligence / Profile preview

Viagra in IUGR and PET

NCT00347867Phase 4Unknown

Sponsor
Rambam Health Care Campus
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of sildenafil in intrauterine growth restriction (IUGR) and preeclampsia, sponsored by Rambam Health Care Campus. Primary endpoints: Uteroplacental perfusion measured by ultrasound Doppler velocimetry at 48 hours, Fetal growth and 1 more. Status: unknown.

02

Drugs

sildenafil
03

Conditions

intrauterine growth restriction (IUGR)preeclampsia

Beyond the preview

Go deeper on NCT00347867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00347867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call